The Learning Portal will be under maintenance Monday, 6 December between 6 AM and 5 PM EST. Portal functionality will be unavailable during this window.
We apologize for any inconvenience caused during this time.

  • Feature ArticlesFeature Articles

    Legal Issues in Digital Pharmaceutical Communication in the EU--Part 3

    In March 2011, the European Commission launched a public consultation on an updated eHealth Action Plan for the period 2012-2020 1 , which had been called upon by the Council Conclusions on Safe and Efficient Healthcare through eHealth of December 2009 2 , and superseded the first plan adopted in 2004. Similarly, the US Food and Drug Administration (FDA) promotes the development of mobile medical apps that provide consumers and healthcare professionals with valuable he...
  • Feature ArticlesFeature Articles

    The French Act N°2011-2012: Boosting Safety or Creating a Storm?

    The scandal surrounding French adjuvant therapy in hypertriglyceridemia and overweight diabetics drug Médiator, and the many deaths apparently linked to the product directly led to enactment of  The French Act N°2011-2012   of 29 December 2011 by the National Assembly. The law, sponsored by France's Ministry of Labor, Employment and Health to restore public confidence and enhance the safety of medicinal and health products, affects all stakeholders ...